Two of the companies behind one of the leading COVID-19 vaccine candidates will seek approval from the U.S. Food and Drug Administration for emergency use authorization (EUA) of their preventative treatment with an application to be delivered today [Update: Pfizer confirmed the application was submitted as promised later Friday afternoon]. Pfizer and BioNTech, which revealed … Continue reading Pfizer and BioNTech to submit request for emergency use approval of their COVID-19 vaccine today